NeuBase Therapeutics, Inc. Quarterly Operating Lease, Liability in USD from Q2 2021 to Q3 2022

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: NeuBase Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from Q2 2021 to Q3 2022.
NeuBase Therapeutics, Inc. Operating Lease, Liability for the quarter ending September 30, 2022 was $5.89M, a 4.67% decline year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2022	$5.89M	-$288K	-4.67%	Sep 30, 2022	10-K	2022-12-21
Q4 2021	$6.11M			Dec 31, 2021	10-Q	2022-02-11
Q3 2021	$6.18M			Sep 30, 2021	10-K	2021-12-23
Q2 2021	$6.18M			Jun 30, 2021	10-Q	2021-08-13

* An asterisk sign (*) next to the value indicates that the value is likely invalid.